Market open
Curis/$CRIS
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Curis
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Ticker
$CRIS
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
34
ISIN
US2312693094
Website
Curis Metrics
BasicAdvanced
$21M
-
-$6.03
3.65
-
Price and volume
Market cap
$21M
Beta
3.65
52-week high
$13.48
52-week low
$1.02
Average daily volume
111K
Financial strength
Current ratio
2.358
Quick ratio
1.123
Long term debt to equity
-390.737
Total debt to equity
-519.918
Interest coverage (TTM)
-36.19%
Management effectiveness
Return on assets (TTM)
-52.08%
Return on equity (TTM)
-2,951.24%
Valuation
Price to revenue (TTM)
1.247
Price to book
-3.17
Price to tangible book (TTM)
-1.35
Price to free cash flow (TTM)
-0.416
Growth
Revenue change (TTM)
14.17%
Earnings per share change (TTM)
-30.09%
3-year revenue growth (CAGR)
2.13%
3-year earnings per share growth (CAGR)
-19.01%
What the Analysts think about Curis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Curis stock.
Curis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Curis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Curis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Curis stock?
Curis (CRIS) has a market cap of $21M as of May 16, 2025.
What is the P/E ratio for Curis stock?
The price to earnings (P/E) ratio for Curis (CRIS) stock is 0 as of May 16, 2025.
Does Curis stock pay dividends?
No, Curis (CRIS) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Curis dividend payment date?
Curis (CRIS) stock does not pay dividends to its shareholders.
What is the beta indicator for Curis?
Curis (CRIS) has a beta rating of 3.65. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.